These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 32017652)

  • 1. Plasma Circulating Tumor HPV DNA for the Surveillance of Cancer Recurrence in HPV-Associated Oropharyngeal Cancer.
    Chera BS; Kumar S; Shen C; Amdur R; Dagan R; Green R; Goldman E; Weiss J; Grilley-Olson J; Patel S; Zanation A; Hackman T; Blumberg J; Patel S; Thorp B; Weissler M; Yarbrough W; Sheets N; Mendenhall W; Tan XM; Gupta GP
    J Clin Oncol; 2020 Apr; 38(10):1050-1058. PubMed ID: 32017652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative Circulating Tumor HPV DNA and Oropharyngeal Squamous Cell Disease.
    Lam D; Sangal NR; Aggarwal A; Rajasekaran K; Cannady SB; Basu D; Chalian A; Weinstein G; Brody RM
    JAMA Otolaryngol Head Neck Surg; 2024 May; 150(5):444-450. PubMed ID: 38573644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-free human papillomavirus DNA kinetics after surgery for human papillomavirus-associated oropharyngeal cancer.
    O'Boyle CJ; Siravegna G; Varmeh S; Queenan N; Michel A; Pang KCS; Stein J; Thierauf JC; Sadow PM; Faquin WC; Wang W; Deschler DG; Emerick KS; Varvares MA; Park JC; Clark JR; Chan AW; Busse PM; Corcoran RB; Wirth LJ; Lin DT; Iafrate AJ; Richmon JD; Faden DL
    Cancer; 2022 Jun; 128(11):2193-2204. PubMed ID: 35139236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid Clearance Profile of Plasma Circulating Tumor HPV Type 16 DNA during Chemoradiotherapy Correlates with Disease Control in HPV-Associated Oropharyngeal Cancer.
    Chera BS; Kumar S; Beaty BT; Marron D; Jefferys S; Green R; Goldman EC; Amdur R; Sheets N; Dagan R; Hayes DN; Weiss J; Grilley-Olson JE; Zanation A; Hackman T; Blumberg JM; Patel S; Weissler M; Tan XM; Parker JS; Mendenhall W; Gupta GP
    Clin Cancer Res; 2019 Aug; 25(15):4682-4690. PubMed ID: 31088830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating tumor HPV DNA in the management of HPV+ oropharyngeal cancer and its correlation with MRI.
    Campo F; Paolini F; Manciocco V; Moretto S; Pichi B; Moretti C; Blandino G; De Pascale V; Benevolo M; Pimpinelli F; Vidiri A; Marzi S; Ruggiero S; Terrenato I; Iocca O; Venuti A; Pellini R
    Head Neck; 2024 Sep; 46(9):2206-2213. PubMed ID: 38979763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detectable Postoperative Circulating Tumor Human Papillomavirus DNA and Association with Recurrence in Patients With HPV-Associated Oropharyngeal Squamous Cell Carcinoma.
    Routman DM; Kumar S; Chera BS; Jethwa KR; Van Abel KM; Frechette K; DeWees T; Golafshar M; Garcia JJ; Price DL; Kasperbauer JL; Patel SH; Neben-Wittich MA; Laack NL; Chintakuntlawar AV; Price KA; Liu MC; Foote RL; Moore EJ; Gupta GP; Ma DJ
    Int J Radiat Oncol Biol Phys; 2022 Jul; 113(3):530-538. PubMed ID: 35157995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Negative Predictive Value of Circulating Tumor Tissue Modified Viral (TTMV)-HPV DNA for HPV-driven Oropharyngeal Cancer Surveillance.
    Hanna GJ; Roof SA; Jabalee J; Rettig EM; Ferrandino R; Chen S; Posner MR; Misiukiewicz KJ; Genden EM; Chai RL; Sims J; Thrash E; Stern SJ; Kalman NS; Yarlagadda S; Raben A; Clements L; Mendelsohn A; Kaczmar JM; Pandey Y; Bhayani M; Gupta P; Kuperwasser C; Del Vecchio Fitz C; Berger BM
    Clin Cancer Res; 2023 Oct; 29(20):4306-4313. PubMed ID: 37566241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From planned neck dissection to PET response to circulating tumour DNA: changes in post-treatment assessment of HPV-driven oropharyngeal cancer
    Post CM; Ohaegbulam KC; Mitin T
    J Med Radiat Sci; 2024 Mar; 71(1):21-25. PubMed ID: 37715340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma Cell-Free Human Papillomavirus Oncogene E6 and E7 DNA Predicts Outcome in Oropharyngeal Squamous Cell Carcinoma.
    Reder H; Taferner VF; Wittekindt C; Bräuninger A; Speel EM; Gattenlöhner S; Wolf G; Klussmann JP; Wuerdemann N; Wagner S
    J Mol Diagn; 2020 Nov; 22(11):1333-1343. PubMed ID: 32822851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating tumor HPV DNA assessments after surgery for human papilloma virus-associated oropharynx carcinoma.
    Souza SS; Stephens EM; Bourdillon AT; Bhethanabotla R; Farzal Z; Plonowska-Hirschfeld K; Qualliotine JR; Heaton CM; Ha PK; Ryan WR
    Am J Otolaryngol; 2024; 45(2):104184. PubMed ID: 38101135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HPV circulating tumoral DNA quantification by droplet-based digital PCR: A promising predictive and prognostic biomarker for HPV-associated oropharyngeal cancers.
    Veyer D; Wack M; Mandavit M; Garrigou S; Hans S; Bonfils P; Tartour E; Bélec L; Wang-Renault SF; Laurent-Puig P; Mirghani H; Rance B; Taly V; Badoual C; Péré H
    Int J Cancer; 2020 Aug; 147(4):1222-1227. PubMed ID: 31756275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing the feasibility of a multimodal liquid biopsy for the diagnosis of HPV-associated oropharyngeal squamous cell carcinoma.
    Lewis JS; Naegele S; Efthymiou V; Mehrad M; Ely KA; Waterboer T; Lang Kuhs KA; Davis SJ; Richard K; Das D; Faden DL
    Am J Clin Pathol; 2024 Jun; 161(6):570-578. PubMed ID: 38349613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The landscape of circulating tumor HPV DNA and TTMV-HPVDNA for surveillance of HPV-oropharyngeal carcinoma: systematic review and meta-analysis.
    Campo F; Iocca O; Paolini F; Manciocco V; Moretto S; De Virgilio A; Moretti C; Vidiri A; Venuti A; Bossi P; Blandino G; Pellini R
    J Exp Clin Cancer Res; 2024 Aug; 43(1):215. PubMed ID: 39095868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of circulating tumor DNA by targeting human papilloma virus-derived sequences as a biomarker in p16-positive oropharyngeal cancer.
    Akashi K; Sakai T; Fukuoka O; Saito Y; Yoshida M; Ando M; Ito T; Murakami Y; Yamasoba T
    Sci Rep; 2022 Jan; 12(1):572. PubMed ID: 35022425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double trouble: Synchronous and metachronous primaries confound ctHPVDNA monitoring.
    Naegele S; Efthymiou V; Hirayama S; Zhao BY; Das D; Chan AW; Richmon JD; Iafrate AJ; Faden DL
    Head Neck; 2023 Jun; 45(6):E25-E30. PubMed ID: 37080924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Oral Human Papillomavirus DNA Persistence With Cancer Progression After Primary Treatment for Oral Cavity and Oropharyngeal Squamous Cell Carcinoma.
    Fakhry C; Blackford AL; Neuner G; Xiao W; Jiang B; Agrawal A; Gillison ML
    JAMA Oncol; 2019 Jul; 5(7):985-992. PubMed ID: 31046104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liquid Biopsies with Circulating Plasma HPV-DNA Measurements-A Clinically Applicable Surveillance Tool for Patients with HPV-Positive Oropharyngeal Cancer.
    Jakobsen KK; Bendtsen SK; Pallisgaard N; Friborg J; Lelkaitis G; Grønhøj C; von Buchwald C
    Clin Cancer Res; 2023 Oct; 29(19):3914-3923. PubMed ID: 37477909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus circulating tumor DNA: a diagnostic tool in squamous cell carcinoma of unknown primary-a pilot study.
    Kais A; Santiago SP; Han PC; Clump DA; Stokes WA; Fancy T; Cui R; Martin E; Turner MT
    Front Oncol; 2024; 14():1376595. PubMed ID: 38628671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes after primary intensity-modulated radiation therapy for oropharyngeal squamous cell carcinoma at a New Zealand regional cancer centre: Impact of p16 status.
    Maqsood S; Jameson MB; De Groot C; Hartopeanu C; Yasin NABHM; Thotathil Z
    Cancer Rep (Hoboken); 2018 Jun; 1(1):e1001. PubMed ID: 32729235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 12 week PET-CT has low positive predictive value for nodal residual disease in human papillomavirus-positive oropharyngeal cancers.
    Rulach R; Zhou S; Hendry F; Stobo D; James A; Dempsey MF; Grose D; Lamb C; Schipani S; Rizwanullah M; Wilson C; Paterson C
    Oral Oncol; 2019 Oct; 97():76-81. PubMed ID: 31437587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.